26 results on '"Fernandez-Enright, Francesca"'
Search Results
2. Alterations of p75 neurotrophin receptor and Myelin transcription factor 1 in the hippocampus of perinatal phencyclidine treated rats
3. A decade from discovery to therapy: Lingo-1, the dark horse in neurological and psychiatric disorders
4. Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia
5. Genetic variants in Nogo receptor signaling pathways may be associated with early life adversity in schizophrenia susceptibility
6. Shifting towards a model of mGluR5 dysregulation in schizophrenia: Consequences for future schizophrenia treatment
7. Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation
8. Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics
9. Structural contributions of antipsychotic drugs to their therapeutic profiles and metabolic side effects
10. Effects of GRASP variation on memory in psychiatrically healthy individuals and cognitive dysfunction in schizophrenics
11. KIBRA rs17070145 polymorphism and resting EEG spectral activity: Biomarkers for reduced risk of Alzheimer’s disease
12. NMDA receptor antagonism by phencyclidine reduces NWASP and WAVE1 protein expression and reduces levels of myelination markers in the prefrontal cortex of rats
13. The effects of catechol-O-methyltransferase polymorphism Val158Met on resting EEG spectral activity in healthy adults
14. Molecular evidence of synaptic pathology in the CA1 region in schizophrenia
15. Possibility of a sex-specific role for a genetic variant in FRMPD4 in schizophrenia, but not cognitive function
16. Lingo-1: a novel target in therapy for Alzheimer′s disease?
17. NMDA Receptor Antagonism by Phencyclidine Reduces NWASP and WAVE1 Protein Expression and Reduces Levels of Myelination Markers in the Prefrontal Cortex of Rats
18. Poster #S173 METABOTROPIC GLUTAMATE RECEPTOR 5 DYSREGULATION IN SCHIZOPHRENIA
19. Investigation of genetic variants in ubiquitin enzyme genes involved in the modulation of neurodevelopmental processes: a role in schizophrenia susceptibility?
20. In Vivo Pharmacological Evaluations of Novel Olanzapine Analogues in Rats: A Potential New Avenue for the Treatment of Schizophrenia
21. Novel olanzapine analogues presenting a reduced H1 receptor affinity and retained 5HT2A/D2 binding affinity ratio
22. Structural contributions of antipsychotic drugs to their therapeutic profiles and metabolic side effects
23. Research Paper. Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics.
24. In Vivo Pharmacological Evaluations of Novel Olanzapine Analogues in Rats: A Potential New Avenue for the Treatment of Schizophrenia.
25. Novel olanzapine analogues presenting a reduced H1 receptor affinity and retained 5HT2A/D2 binding affinity ratio.
26. Genetic variants in Nogo receptor signaling pathways may be associated with early life adversity in schizophrenia susceptibility.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.